Welcome to the Cerba Research Oncology Blog — where science meets practical execution. Our global oncology experts translate complex science into clear, actionable insight, sharing how advanced laboratory techniques are shaping today’s clinical trials. From flow cytometry and IHC to NGS and multiplexed strategies, we explore how integrated biomarker solutions accelerate smarter decision‑making in immuno-oncology.
Why Read Our Blog
This blog brings together practical insights from Cerba Research’s experience supporting early-phase oncology studies. Expect clear explanations of biomarker approaches, real examples from laboratory workflows, and guidance on integrating techniques such as flow cytometry, IHC, and NGS to support decision-making in immuno‑oncology.
